NF-κB activation has also been linked to autism [295,296,297,298], Alzheimer’s disease [299,300,301,302], Parkinson’s disease [303,304] and multiple sclerosis [305,306]. Here, NFKB1 is linked to early-onset autosomal dominant Alzheimer disease.